ALLOPLEX BIOTHERAPEUTICS Trademark

Trademark Overview

On Friday, March 29, 2019, a trademark application was filed for ALLOPLEX BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALLOPLEX BIOTHERAPEUTICS trademark a serial number of 88362644. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 25, 2024. This trademark is owned by Alloplex Biotherapeutics, Inc.. The ALLOPLEX BIOTHERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of immuno-oncology; scientific research and development; and scientific research consulting in the field of immuno-oncology
alloplex biotherapeutics

General Information

Serial Number88362644
Word MarkALLOPLEX BIOTHERAPEUTICS
Filing DateFriday, March 29, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 25, 2020

Trademark Statements

Description of MarkThe mark consists of the stylized term "ALLOPLEX" to the left of a design of curved lines surrounding a circle, displayed above the stylized term "BIOTHERAPEUTICS" .
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOTHERAPEUTICS ENGINEERING ADVANCED CELLULAR THERAPIES"
Goods and ServicesProviding medical and scientific research information in the field of immuno-oncology; scientific research and development; and scientific research consulting in the field of immuno-oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2019
Primary Code042
First Use Anywhere DateTuesday, October 11, 2022
First Use In Commerce DateTuesday, October 11, 2022

Trademark Owner History

Party NameAlloplex Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWinchester, MA 01890
Party NameAlloplex Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinchester, MA 01890

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 25, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, November 9, 2023DATA MODIFICATION COMPLETED
Thursday, November 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 10, 2023USE AMENDMENT FILED
Tuesday, October 10, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, March 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU EXTENSION 5 GRANTED
Friday, March 17, 2023SOU EXTENSION 5 FILED
Wednesday, March 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 17, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2022SOU EXTENSION 4 GRANTED
Thursday, October 6, 2022SOU EXTENSION 4 FILED
Thursday, October 6, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 6, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 6, 2022SOU EXTENSION 3 FILED
Wednesday, April 6, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 6, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 2 FILED
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 8, 2021SOU EXTENSION 1 GRANTED
Thursday, April 8, 2021SOU EXTENSION 1 FILED
Thursday, April 8, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 20, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 20, 2020ASSIGNED TO LIE
Friday, July 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 16, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, July 16, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 16, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, July 16, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 31, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 31, 2019FINAL REFUSAL E-MAILED
Tuesday, December 31, 2019FINAL REFUSAL WRITTEN
Thursday, December 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 11, 2019NON-FINAL ACTION WRITTEN
Monday, June 10, 2019ASSIGNED TO EXAMINER
Thursday, April 18, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2019NEW APPLICATION ENTERED

Related Keywords

biotherapeutics alloplex scientific research immuno oncology field development consulting information medical providing